Gunjan Verma - India

Manufacturers will need to provide updated documentation, including the ISO 13485 certificate, Free Sale Certificate (FSC), and other updated documents, in order to complete the retention process.

Gunjan Verma
Managing Partner
Asia Actual India

Come grow with us in the US in Thailand in China in Korea in the Philippines in Taiwan in Hong Kong

Sources and Links

Sign Up For Our Newsletter to Stay Informed

Sign Up

India’s CDSCO Releases Guidance for Renewing Medical Device Import Licenses

Published on: March 24th, 2023

India’s CDSCO has issued important guidance on the process for medical device Import License renewal. This process is newly coming into effect, as the first round of Import Licenses issued under the new Rules will start to expire this year (after the 5-year validity period). The update includes important information on retention fees and required documents.

Please contact Asia Actual here if you have any questions regarding this recent update to the CDSCO import license retention process, or if you require support in the renewal process.

Steps to Renew Medical Device Import Licenses from India’s CDSCO

Outlined in the Medical Device Rules, 2017, manufacturers must renew their Import License(s) every five (5) years to retain market access in India. Given that the Medical Devices Rules, 2017, were implemented in 2018, the first round of Import Licenses approved under the new rules are set to expire later in 2023, this year.

Renewing an Import License includes two steps; (1) paying the retention fees and (2) submitting the updated documents. Import licenses obtained for manufacturing sites and medical devices are valid in perpetuity as long as the retention fees are paid and updated documents are submitted every five years. The list of retention fees and documents can be found below.

Import License Retention Fees in India

Manufacturers seeking to retain market access will need to pay Retention fees every 5 years for each Import License (manufacturing site) and each Endorsement (product registration). These fees range from US$50 for a Class A device to US$3,000 for Class D Import License and are the same as the initial application’s fee.

The fees, specified in the Second Schedule of MDR 2017, apply to each overseas manufacturing site and each approved medical device is endorsed to the license.

The initial application, and retention fees, are as follows:

Class A Medical Device US$1,000 US$50
Class B Medical Device US$2,000 US$1,000
Class C Medical Device US$3,000 US$1,500
Class D Medical Device US$3,000 US$1,500
Class A in-Vitro Diagnostic US$1,000 US$50
Class B in-Vitro Diagnostic US$1,000 US$50
Class C in-Vitro Diagnostic US$3,000 US$500
Class D in-Vitro Diagnostic US$3,000 US$500

It is important to note that retention fees are due every 5 years from the date for which the specific Import License or Endorsement was originally approved. Therefore, if an Import License with 1 product is approved in 2018 and then 2 more products are added in 2020, the manufacturer will need to pay the government fees for 1 Import License (Plant Master File) and 1 Endorsement (Device Master File) in 2023 while the other 2 products will be renewed in 2025. The fee will stay the same amount as the original fee and is in accordance with the Classification of the manufacturing site, or the Classification of the product.

Documentation Requirements for India Retention

The CDSCO MD’s Online checklist mandates submission of the following documents and information as part of the process for the retention of import licenses:

  1. Application and intention forms,
  2. Copy of all licenses, approvals, and endorsements related to the MD-15 Import License,
  3. List of products being removed from the license (if applicable),
  4. Declaration from the manufacturer confirming there are no changes,
  5. Sales data by product,
  6. Post market surveillance reports,
  7. Free Sale Certificate from National Regulatory Authority of country of origin and following six reference countries: USA, EU, UK, Canada, Japan, Australia – both are required.
  8. Updates ISO 13485 certificate,
  9. Copy of any post approval changes,
  10. Additional information,
  11. Retention fees based on manufacturing site and individual products listed.

Manufacturers will want to ensure the they possess the above documentation in order to successfully renew their import license. A Retention Certificate will be issued once the retention fee is paid and the documents submitted online are reviewed and approved by CDSCO.

Amendments: The system does not allow for amendments during the renewal and updates to the product will need to be made separately. The renewal process requires a declaration from the manufacturer that no changes have been made to the product or manufacturing process. Manufacturers should be vigilant with license maintenance in India in order to avoid complications and delays in the license renewal process, which could interrupt market access.

Late Fees: Retention fees are to be submitted for maintenance of the perpetual import licenses. The fees can be paid after the renewal date but will incur a late fee.

Come Grow With Us

Please contact us if you need more information on import license renewal in India. Asia Actual has an office in India located in Delhi staffed by experienced, bilingual regulatory and commercial professionals that will address any questions or provide support.

Asia Actual is a regulatory consulting company focused on helping manufacturers grow sales in challenging Asia markets through device registration, independent license holding, direct fulfilment, and a variety of sales channel support services.

Blog Posts

New Hong Kong Medical Device Regulations Office Centre

Hong Kong Prepares Office for Mandatory Medical Device Regulations

On June 5th, Hong Kong's Department of Health (DH) announced plans for the establishment of the Centre for Medical Products Regulation (CMPR).
Ai as a Medical Device and Machine Learning Medical Device in Australia by Asia Actual

Australia Issues New Guidance on AIMD and MLMD

On May 9th, 2024, Australia's Therapeutic Goods Administration (TGA) updated its guidance for AI Medical Devices and Machine Learning Medical Devices.

India Extends Deadline for Class C and D Import Licenses

On May 16th, 2024 India's CDSCO extended allowances for the importation of Class C and D Medical Devices currently under review.